OPTISYL
ActiveSummary
OPTISYL has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €11,260 and a net result of €19,453. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 27% of 22,382 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
18-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 18 days late
2024
31-12
Financial
Back to profitnet €21,158
Net result €21,158 after 3 loss-making years.
08-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 8 days late
2023
28-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 28 days late
2022
31-12
Financial
Weakest financial yearnet -€1,657
Net result drops to -€1,657, the lowest in the series; recovery starts the following year.
18-10
NBB filing
Annual accounts filed
financial year 2021 · micro format · 79 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.